|
CONCURRENT ADMINISTRATION MAY CAUSE BRADYCARDIA, MYOCARDIAL DEPRESSION OR A.V. BLOCK
|
CONCURRENT ADMINISTRATION MAY CAUSE BRADYCARDIA, MYOCARDIAL DEPRESSION OR A.V. BLOCK
|
POTENTIATION OF ORTHOSTATIC HYPOTENSION
|
POTENTIATION OF ORTHOSTATIC HYPOTENSION
|
POTENTIATION OF ORTHOSTATIC HYPOTENSION
|
POTENTIATION OF ORTHOSTATIC HYPOTENSION
|
POTENTIATION OF ORTHOSTATIC HYPOTENSION
|
POTENTIATION OF ORTHOSTATIC HYPOTENSION
|
POTENTIATION OF ORTHOSTATIC HYPOTENSION
|
POTENTIATION OF ORTHOSTATIC HYPOTENSION
|
POTENTIATION OF ORTHOSTATIC HYPOTENSION
|
ANTAGONISE ANTIHYPERTENSIVE EFFECT OF THE DRUG
|
ANTAGONISE ANTIHYPERTENSIVE EFFECT OF THE DRUG
|
CO-ADMINISTRATION MAY ANTAGONISE ANTIHYPERTENSIVE EFFECT OF THE DRUG
|
CO-ADMINISTRATION MAY ANTAGONISE ANTIHYPERTENSIVE EFFECT OF THE DRUG
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
MAOIS CAN CAUSE SEVERE HYPOTENSION WHEN GIVEN CONCURRENTLY
|
MAOIS CAN CAUSE SEVERE HYPOTENSION WHEN GIVEN CONCURRENTLY
|
MAOIS CAN CAUSE SEVERE HYPOTENSION WHEN GIVEN CONCURRENTLY
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS HYPERTENSIVE & VASOCONSTRICTOR EFFECT IS POTENTIATED BY THE DRUG
|
SIGNS OF HYPOGLYCEMIA MAY BE REDUCED OR ABSENT
|
SIGNS OF HYPOGLYCEMIA MAY BE REDUCED OR ABSENT
|
SIGNS OF HYPOGLYCEMIA MAY BE REDUCED OR ABSENT
|
FRUSEMIDE MAY ADD TO OR POTENTIATE THE THERAPEUTIC OF OTHER ANTIHYPERTENSIVE DRUGS
|
FRUSEMIDE MAY ADD TO OR POTENTIATE THE THERAPEUTIC OF OTHER ANTIHYPERTENSIVE DRUGS
|
FRUSEMIDE MAY ADD TO OR POTENTIATE THE THERAPEUTIC OF OTHER ANTIHYPERTENSIVE DRUGS
|
FRUSEMIDE MAY ADD TO OR POTENTIATE THE THERAPEUTIC OF OTHER ANTIHYPERTENSIVE DRUGS
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
TRICYCLIC ANTIDEPRESSANTS MAY REDUCE THE ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
PHENOTHIAZINES LIKE CHLORPROMAZINE REVERSES ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
PHENOTHIAZINES LIKE CHLORPROMAZINE REVERSES ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
PHENOTHIAZINES LIKE CHLORPROMAZINE REVERSES ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
PHENOTHIAZINES LIKE CHLORPROMAZINE REVERSES ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
PHENOTHIAZINES LIKE CHLORPROMAZINE REVERSES ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
PHENOTHIAZINES LIKE CHLORPROMAZINE REVERSES ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
PHENOTHIAZINES LIKE CHLORPROMAZINE REVERSES ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
PHENOTHIAZINES LIKE CHLORPROMAZINE REVERSES ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
PHENOTHIAZINES LIKE CHLORPROMAZINE REVERSES ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
PHENOTHIAZINES LIKE CHLORPROMAZINE REVERSES ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
PHENOTHIAZINES LIKE CHLORPROMAZINE REVERSES ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
PHENOTHIAZINES LIKE CHLORPROMAZINE REVERSES ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
PHENOTHIAZINES LIKE CHLORPROMAZINE REVERSES ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
PHENOTHIAZINES LIKE CHLORPROMAZINE REVERSES ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
PHENOTHIAZINES LIKE CHLORPROMAZINE REVERSES ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|
PHENOTHIAZINES LIKE CHLORPROMAZINE REVERSES ANTIHYPERTENSIVE EFFECTS OF THE DRUG
|